Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Aequis
- ·The full record, as it builds
Funding rounds
No funding rounds for Aequis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aequis
Provider of hormone optimization telehealth care services intended to make hormone therapy and related medical treatments accessible through remote clinical services. The company offers hormone replacement therapy, peptide therapy, metabolic weight management, and US peptide therapy , enabling patients to access online hormone treatment and medical oversight.
- Sector
- Healthcare
- HQ
- Eagle, ID, United States
- Website
- aequiscare.com/
- Ownership
- Privately Held (backing)
Aequis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aequis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aequis in its N-PORT filings yet. We sweep new filings monthly.